Web Analytics

Investor Profile

Marshall Wace

Marshall Wace United Kingdom - London
INVESTOR

1 Disclosed Funding Rounds $120,000,000
13 Participating Investments




Founded in 1997, Marshall Wace is a global asset manager offering a diverse set of alternative, long-only and bespoke investment solutions to a broad range of investors.

Invested In

Company Date Round Raised
  BlueWhale Bio September, 08 ,2023 Unknown $18,000,000
  Turtlemint April, 29 ,2022 Series E $120,000,000
  Parse Biosciences February, 15 ,2022 Series B $41,500,000
  FogPharma March, 05 ,2024 Series E $145,000,000
  Prognos Health May, 18 ,2023 Unknown $23,000,000
  Attovia Therapeutics May, 14 ,2024 Series B $105,000,000
  ADARx Pharmaceuticals Inc. August, 10 ,2023 Series C $200,000,000
  Inquis Medical, Inc. November, 05 ,2024 Series B $40,000,000
  Beta Bionics September, 04 ,2023 Series D $100,000,000
  BlueWhale Bio September, 08 ,2023 Unknown $18,000,000
  FogPharma March, 05 ,2024 Series E $145,000,000
  Attovia Therapeutics May, 14 ,2024 Series B $105,000,000
  Inquis Medical, Inc. November, 05 ,2024 Series B $40,000,000